Clinical Trials Browser

Phase 1/2 × Nasopharyngeal Carcinoma × Genitourinary × Clear all

Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin

NCT03674567 2025-01-24

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

BreastGenitourinaryGynecologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Lymphoma

NCT03047525 2017-02-09

Study of DC-CTL Combined With CIK for Advanced Solid Tumor

Phase 1/2 Unknown

200 enrolled

GastrointestinalGenitourinaryHead & NeckThoracic

Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Lung Neoplasms, Colorectal Neoplasms

Clinical Trials

Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination with Pembrolizumab

Study of DC-CTL Combined With CIK for Advanced Solid Tumor